6NYB image
Entry Detail
PDB ID:
6NYB
EMDB ID:
Keywords:
Title:
Structure of a MAPK pathway complex
Biological Source:
Host Organism:
PDB Version:
Deposition Date:
2019-02-11
Release Date:
2019-10-09
Method Details:
Experimental Method:
Resolution:
4.10 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Serine/threonine-protein kinase B-raf
Chain IDs:A
Chain Length:805
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Dual specificity mitogen-activated protein kinase kinase 1
Mutations:S218A, S222A
Chain IDs:B
Chain Length:415
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:14-3-3 protein zeta
Chain IDs:C, D
Chain Length:247
Number of Molecules:2
Biological Source:Spodoptera exigua
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
SEP A SER modified residue
Primary Citation
Architecture of autoinhibited and active BRAF-MEK1-14-3-3 complexes.
Nature 575 545 550 (2019)
PMID: 31581174 DOI: 10.1038/s41586-019-1660-y

Abstact

RAF family kinases are RAS-activated switches that initiate signalling through the MAP kinase cascade to control cellular proliferation, differentiation and survival1-3. RAF activity is tightly regulated and inappropriate activation is a frequent cause of cancer4-6; however, the structural basis for RAF regulation is poorly understood at present. Here we use cryo-electron microscopy to determine autoinhibited and active-state structures of full-length BRAF in complexes with MEK1 and a 14-3-3 dimer. The reconstruction reveals an inactive BRAF-MEK1 complex restrained in a cradle formed by the 14-3-3 dimer, which binds the phosphorylated S365 and S729 sites that flank the BRAF kinase domain. The BRAF cysteine-rich domain occupies a central position that stabilizes this assembly, but the adjacent RAS-binding domain is poorly ordered and peripheral. The 14-3-3 cradle maintains autoinhibition by sequestering the membrane-binding cysteine-rich domain and blocking dimerization of the BRAF kinase domain. In the active state, these inhibitory interactions are released and a single 14-3-3 dimer rearranges to bridge the C-terminal pS729 binding sites of two BRAFs, which drives the formation of an active, back-to-back BRAF dimer. Our structural snapshots provide a foundation for understanding normal RAF regulation and its mutational disruption in cancer and developmental syndromes.

Legend

Protein

Chemical

Disease

Primary Citation of related structures